AMZN
Amazon.com, Inc.
AMZN has the edge over LE overall, supported by stronger fundamentals and lower modeled downside.
LE
Lands' End, Inc.
LE trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
LE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Strong |
LE's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
LE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 0.8x | $8.92 | — |
| Cheap | 13x | $142 | +1490% |
| Forward | 15x | $8.92 | — |
| Fair | 38x | $426 | +4674% |
| Expensive | 68x | $765 | +8479% |
Historical ranges are pointers, not guarantees.
LE has the edge over AMZN in the historical PE scenario, which offers more potential upside but is not a forecast.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over LE on the outlook, with more favorable earnings and revenue expectations.
LE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect LE's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over LE on earnings, with more consistent year-over-year improvement.
LE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.59 | -95% |
| Q3 2026 | $11.24 | +6144% |
| Q2 2026 | $11.01 | +8369% |
| Q1 2026 | $0.18 | -10% |
| Q4 2025 | $0.37 | +$1.03 |
| Q3 2025 | $0.18 | +$4.34 |
| Q2 2025 | $0.13 | +$4.37 |
| Q1 2025 | $0.20 | +$4.29 |
| Q4 2024 | -$0.66 | +$3.26 |
LE's earnings per share have jumped to their highest in seven years: $11.24 over the past year, up from $0.18 the year before. Its recent earnings include one-off gains.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over LE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over LE on profitability, with a higher operating margin.
LE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $268.9M | +5.3% |
| Q2 2026 | $205.1M | -9.9% |
| Q1 2026 | $402.3M | -8.9% |
| Q4 2025 | $277.5M | -13% |
| Q3 2025 | $255.3M | -20% |
| Q2 2025 | $227.8M | -20% |
| Q1 2025 | $441.7M | -14% |
| Q4 2024 | $318.6M | -1.9% |
LE's revenue is recovering but still below its 2022 peak: $269M last quarter, up 5.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3% | +1.5 points |
| Q2 2026 | -22% | -21 points |
| Q1 2026 | 6.4% | -1.9 points |
| Q4 2025 | 6% | +3.1 points |
| Q3 2025 | 1.6% | +0.8 points |
| Q2 2025 | -1% | -1.8 points |
| Q1 2025 | 8.4% | +6.8 points |
| Q4 2024 | 2.9% | +34 points |
LE's operating margin was 3% last quarter, up 1.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
LE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$26.1M | -286% |
| Q2 2026 | -$84.4M | -$53.7M |
| Q1 2026 | $59.5M | +20% |
| Q4 2025 | -$22.4M | +$5.4M |
| Q3 2025 | $14.1M | -46% |
| Q2 2025 | -$30.7M | +$1.8M |
| Q1 2025 | $49.7M | -43% |
| Q4 2024 | -$27.8M | -$4M |
LE has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
LE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.9% | -1.2M shares |
| 1 year | -2.1% | -635K shares |
| 3 years | -6.3% | -2M shares |
| 5 years | -11% | -3.6M shares |
| Available history | -7.1% | -2.3M shares |
LE has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2024 | $1M |
| Q1 2024 | $2.1M |
| Q4 2023 | $3M |
| Q3 2023 | $3M |
| Q2 2023 | $3.8M |
| Q1 2023 | $3.2M |
| Q4 2022 | $2.9M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
LE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 3.6x | Elevated |
LE has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
LE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 3.0 | Oversold |
LE's weekly RSI is 33 (neutral) and its Stochastic is 3 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
LE PE vs Consumer Cyclical Sector
| Metric | LE | Sector median | Relative |
|---|---|---|---|
| PE | 0.8x | 18x | 96% below |
| PE % | 0 | 47 | 47 pts below |
LE has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over LE on trend strength, trading above more of its moving averages.
LE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.78 | 8.8% below |
| 20 week MA | $10.9 | 18% below |
| 50 week MA | $12.7 | 30% below |
| 100 week MA | $12.4 | 28% below |
| 200 week MA | $11.6 | 23% below |
LE is in a downtrend: it's below all five of its weekly moving averages, and 23% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over LE on returns for 2026, with the stronger performance.
LE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.6 | $19.8 | +13% |
| 2021 | $19.8 | $19.1 | -3.6% |
| 2022 | $19.1 | $7.21 | -62% |
| 2023 | $7.21 | $9.56 | +33% |
| 2024 | $9.56 | $13.4 | +40% |
| 2025 | $13.4 | $14.6 | +9.2% |
| 2026 YTD | $14.6 | $8.92 | -39% |
LE is down 39% so far in 2026, after finishing higher in four of the previous six years.